anordrin and Endometrial-Neoplasms

anordrin has been researched along with Endometrial-Neoplasms* in 1 studies

Other Studies

1 other study(ies) available for anordrin and Endometrial-Neoplasms

ArticleYear
Anordrin Eliminates Tamoxifen Side Effects without Changing Its Antitumor Activity.
    Scientific reports, 2017, 03-07, Volume: 7

    Tamoxifen is administered for estrogen receptor positive (ER

    Topics: Animals; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Contraceptives, Oral, Synthetic; Endometrial Neoplasms; Female; Heterografts; Humans; Mice, Inbred ICR; Mice, Nude; Neoplasm Transplantation; Non-alcoholic Fatty Liver Disease; Norandrostanes; Tamoxifen; Treatment Outcome

2017